Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Infarma - Pharmaceutical Sciences is Scopus-indexed (Q4, CiteScore 0.1), DOAJ. Published by Conselho Federal de Farmacia.
Checked against the index lists dated .
ISSN 0104-0219Verify ISSN ↗2318-9312Verify ISSN ↗
Publisher: Conselho Federal de Farmacia
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (all) | 79 / 79 | 0th | Q4 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q4, CiteScore 0.1.
Infarma - Pharmaceutical Sciences is Q4 in Pharmacology, Toxicology and Pharmaceutics (all) (rank 79 of 79), by CiteScore 2025.
Infarma - Pharmaceutical Sciences is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.1, quartile Q4, 0th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.108, quartile Q4, with an H-index of 4.
Infarma - Pharmaceutical Sciences is published by Conselho Federal de Farmacia. Its print ISSN is 0104-0219 and its online ISSN is 2318-9312.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Infarma - Pharmaceutical Sciences has an h-index of 14 and a 2-year mean of 0.1 citations per paper (OpenAlex). Its Scopus CiteScore is 0.1, quartile Q4. On 2-year citations it ranks #68 of 77 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (all).
Infarma - Pharmaceutical Sciences published 11 papers in 2025; its busiest recent year was 2017 with 50. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 83 research articles (2022–2026), authors are most often from Brazil (84.3%), Paraguay (4.2%) and Russia (2.4%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.